AU7469494A - Anthelmintic formulations - Google Patents

Anthelmintic formulations

Info

Publication number
AU7469494A
AU7469494A AU74694/94A AU7469494A AU7469494A AU 7469494 A AU7469494 A AU 7469494A AU 74694/94 A AU74694/94 A AU 74694/94A AU 7469494 A AU7469494 A AU 7469494A AU 7469494 A AU7469494 A AU 7469494A
Authority
AU
Australia
Prior art keywords
anthelmintic formulations
anthelmintic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU74694/94A
Other versions
AU695582B2 (en
Inventor
Colin Manson Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merial Ltd
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of AU7469494A publication Critical patent/AU7469494A/en
Application granted granted Critical
Publication of AU695582B2 publication Critical patent/AU695582B2/en
Assigned to MERIAL LTD reassignment MERIAL LTD Alteration of Name(s) in Register under S187 Assignors: ASHMONT HOLDINGS LIMITED
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74694/94A 1993-08-24 1994-08-22 Anthelmintic formulations Expired AU695582B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ248486 1993-08-24
NZ248486A NZ248486A (en) 1993-08-24 1993-08-24 Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
PCT/NZ1994/000084 WO1995005812A1 (en) 1993-08-24 1994-08-22 Anthelmintic formulations

Publications (2)

Publication Number Publication Date
AU7469494A true AU7469494A (en) 1995-03-21
AU695582B2 AU695582B2 (en) 1998-08-13

Family

ID=19924458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74694/94A Expired AU695582B2 (en) 1993-08-24 1994-08-22 Anthelmintic formulations

Country Status (5)

Country Link
EP (1) EP0724437A4 (en)
AU (1) AU695582B2 (en)
NZ (1) NZ248486A (en)
WO (1) WO1995005812A1 (en)
ZA (1) ZA946195B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694016B2 (en) * 1995-05-10 1998-07-09 Virbac (Australia) Pty Limited Canine anthelmintic preparation
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
FR2739778B1 (en) * 1995-10-13 1997-12-12 Virbac Lab TOPICAL FORMULATION FOR TREATING LIVER DISEASE DISEASE IN ANIMALS
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
PT1285667E (en) * 1997-11-18 2006-11-30 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AUPP858299A0 (en) * 1999-02-08 1999-03-04 Virbac (Australia) Pty Limited Pesticidal compositions
WO2001020994A1 (en) * 1999-09-22 2001-03-29 Ashmont Holdings Limited Sheep pour-on
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
KR20020067781A (en) * 2001-02-19 2002-08-24 주식회사 엘지씨아이 Anthelmintic injectable composition containing ivermectin and process for preparation thereof
GB2386067A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
FR2839614B1 (en) * 2002-05-14 2004-08-13 Virbac Sa NEW OIL PEST ORAL OIL COMPOSITIONS
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
EP1824474A1 (en) * 2004-12-10 2007-08-29 Bayer HealthCare AG Anthelmintic composition
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CA2622713C (en) * 2005-09-15 2012-07-24 Merial Limited Anthelmintic formulations
BRPI0506279B1 (en) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda SYNERGY COMPOSITION OF ANTIHELMINTICS AND NON-DECATED
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
CN103417477B (en) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 A kind of take water as doractin O/W type injection of substrate and preparation method thereof
NZ701697A (en) 2014-03-24 2016-05-27 Donaghys Ltd Stable veterinary anthelmintic formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470979A (en) * 1982-09-17 1984-09-11 Janssen Pharmaceutica N.V. Chemical sterilization of insects with salicylanilides
AU628671B2 (en) * 1989-10-12 1992-09-17 Michael John Crooks Non-aqueous micellar solutions of various drugs
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
AU3569093A (en) * 1993-04-02 1994-10-20 Barend Willem Hak A veterinary medicament for preventive treatment and therapy of cattle against parasites
EP0710105B1 (en) * 1993-06-15 2003-07-30 The Australian National University Synergistic anthelmintic compositions against fasciola hepatica and other fasciola species

Also Published As

Publication number Publication date
ZA946195B (en) 1995-05-22
EP0724437A4 (en) 1998-07-29
WO1995005812A1 (en) 1995-03-02
AU695582B2 (en) 1998-08-13
EP0724437A1 (en) 1996-08-07
NZ248486A (en) 1996-07-26

Similar Documents

Publication Publication Date Title
AU3560497A (en) Anthelmintic formulations
AUPM969994A0 (en) Equine anthelmintic formulations
AU7469494A (en) Anthelmintic formulations
AU7572196A (en) Pharmaceutical formulations
AU8554691A (en) Improved formulations
AU7309394A (en) Disinfectant composition
AU7265796A (en) Probiotically acting formulation
AU8130391A (en) Solid formulations
AU6010594A (en) Isoxazoleoxy derivative
AU7265596A (en) Probiotically acting formulations
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU5773994A (en) Cable-making compositions
AU6377594A (en) Disinfectant compositions
AU7235394A (en) Stabilized formulation
AU8149294A (en) Disinfectant composition
AU1119895A (en) External preparation
GB9323399D0 (en) Pharmaceutical formulations
GB9311030D0 (en) Pharmaceutical formulations
AU671899B2 (en) 5-O-desosaminylerythronolide derivative
AU4795497A (en) Anthelmintic formulation
AU7467394A (en) Galactosylmoranoline derivative
AU6169294A (en) 15-oxasterols as hypocholesterolemics
EP0742281A3 (en) Fluorescent-whitening agents containing formulations
AU3277993A (en) Anthelmintic beta -ketoamides
AU7083594A (en) Galactosylmoranoline derivative